胎儿中枢神经系统损伤的无创评估:产前诊断的潜在应用
本研究从孕10至19周孕妇血浆中分离胎儿中枢神经系统来源的细胞外囊泡(FCEs),发现当前重度饮酒孕妇的FCEs中突触素、突触结合蛋白、突触足蛋白和神经颗粒素水平均显著降低(P<.001),且微小RNA-9抑制高达十倍(90%);结论提示FCEs可能成为评估胎儿中枢神经系统干细胞增殖分化异常的工具。
要点
- 从孕妇血浆中分离胎儿中枢神经系统来源的细胞外囊泡(FCEs)可行。
- 当前重度饮酒孕妇的FCEs中四种功能蛋白水平均显著降低(P<.001)。
- 突触素和神经颗粒素在暴露组与对照组间无重叠,判别力较强。
核心结论
- 从母体血浆中纯化的FCEs可能成为评估中枢神经系统干细胞增殖和分化异常的有力工具,最早可在晚孕期头三个月进行。
研究设计与样本
- 研究纳入孕10至19周的当前重度饮酒孕妇及匹配对照,从母体血浆中分离FCEs,定量检测突触素、突触结合蛋白、突触足蛋白和神经颗粒素(以CD81归一化),并用特异性引物进行微小RNA-9的定量RT-PCR。
主要发现
- 当前重度饮酒孕妇的FCEs中突触素、突触结合蛋白、突触足蛋白和神经颗粒素水平均显著降低(P<.001)。
- 突触素和神经颗粒素在暴露组与对照组之间无重叠,判别力较强。
- 与对照组相比,酒精暴露胎儿的FCEs中微小RNA-9抑制高达十倍(90%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We have developed novel methods for isolating fetal central nervous system (CNS)-derived extracellular vesicles (FCEs) from maternal plasma as a non-invasive platform for testing aspects of fetal neurodevelopment in early pregnancy. We investigate the hypothesis that levels of defined sets of functional proteins in FCEs can be used to detect abnormalities in fetal neuronal and glial proliferation, differentiation, and survival. METHOD: Maternal plasma was obtained between 10 and 19 weeks from women with current heavy EtOH exposure and matched controls. FCE levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were quantified normalized to the exosome marker CD81. Quantitative RT-PCR was performed with specific primers for miR-9. RESULTS: FCE cargo protein levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were all significantly reduced in pregnancies exposed to current heavy EtOH use (P < .001 for all). Both synaptophysin and neurogranin appeared to be particularly discriminatory with no overlap between exposed and control subjects. Up to tenfold inhibition (90%) in MicroRNA-9 was observed in FCEs from EtOH exposed fetuses compared with controls. CONCLUSION: Our results suggest that FCEs purified from maternal plasma may be a powerful tool to assess abnormal proliferation and differentiation of CNS stem cells as early as the late first trimester. What's already known about this topic? Exosomes/extracellular vesicles (ECVs) are emerging as exciting novel biomarkers in neurologic disease (Alzheimers) What does this study add? Evidence that Fetal CNS ECVs can be isolated from maternal blood The origin of the ECVs appears to be the fetal brain and not the placenta Findings with ECVs correlates with fetal exposure to alcohol. Potential for first trimester prenatal diagnosis of fetal neurologic disease.
引用
- Goetzl L, Darbinian N, Merabova N, et al. Noninvasive assessment of fetal central nervous system insult: Potential application to prenatal diagnosis. Prenat Diagn. 2019. PMID: 31069822. doi:10.1002/pd.5474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。